MedPath

comparative of the effects of Atenolol, Enalapril and Hydrochlorothiazid

Not Applicable
Conditions
Hypertension.
Hypertensive heart disease without (congestive) heart failure
Registration Number
IRCT2012110511371N1
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

All patients with hypertension stage II referred to Buali Hospital in Ardabil; without medications of hypertension; without renal disease (Cr> 1.5); without electrolyte imbalances; no contraindications for use atenolol (asthma, heart block, bradycardia, hypotension); no contraindications for use hydrochlorothiazide (hyperuricemia, initial Hypraldstrvnysm; no contraindications for use enalapril (allergy, renal failure); wishing to participate in the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypertension. Timepoint: Before the experiment, three weeks after intervention. Method of measurement: Mm Hg, using a mercury manometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath